Skip to main content
Top
Published in: European Surgery 3/2022

Open Access 27-04-2022 | Metastasis | main topic

Malignant phyllodes tumor of the breast with axillary lymph node metastasis: case report and review of the literature

Authors: Hubert Hauser, Robert Hammer, Helmut Schöllnast, Ursula Humer-Fuchs, Doris Kriegl, Michael Fuchsjäger, Ferdinand Schmidt, Marija Balic, Sigurd F. Lax

Published in: European Surgery | Issue 3/2022

Login to get access

Excerpt

Phyllodes tumors are fibroepithelial tumors with characteristic histological features. The epithelial component is always benign with luminal and myoepithelial cells, and is surrounded by a cellular mesenchymal component. Phyllodes tumors typically show an exaggerated intracanalicular growth pattern, which results in leaf-like structures projecting into cysts [1]. Since not all phyllodes tumors are cystic, the original name “cystosarcoma phylloides” given by the first describer Johannes Müller (1838) was misleading and later changed by the WHO (1981) to “phyllodes tumor” [2, 3]. According to the current WHO classification, phyllodes tumors are classified as benign, borderline, or malignant based on stromal atypia, stromal cellularity, mitotic rate, stromal overgrowth, and tumor margins [4]. The mesenchymal component determines the biological behavior of the phyllodes tumor. At one end of the spectrum are benign phyllodes tumors with a stroma slightly more cellular than in fibroadenoma and lacking a significant degree of atypia and mitosis, on the other end there are malignant phyllodes tumors with highly atypical and polymorphic stroma with brisk mitotic activity and infiltrative growth into the adjacent tissues. Malignant phyllodes tumors often show an overgrowth by the malignant mesenchymal component, which may lead to a reduction of the epithelial component including the leaf-like pattern and the appearance of a spindle cell neoplasm. …
Literature
1.
go back to reference Koh VCY, Thike AA, Tan PH. Distant metastases in phyllodes tumors of the breast: an overview. Appl Cancer Res. 2017;37(15):1–8. Koh VCY, Thike AA, Tan PH. Distant metastases in phyllodes tumors of the breast: an overview. Appl Cancer Res. 2017;37(15):1–8.
2.
go back to reference Shafi AA, AlHarthi B, Riaz MM, AlBagir A. Gaint phyllodes tumour with axillary & interpectoral lymph node metastasis; a rare presentation. Int J Surg Case Rep. 2020;66:350–5.PubMedCrossRef Shafi AA, AlHarthi B, Riaz MM, AlBagir A. Gaint phyllodes tumour with axillary & interpectoral lymph node metastasis; a rare presentation. Int J Surg Case Rep. 2020;66:350–5.PubMedCrossRef
3.
go back to reference World Health Organization. Histological typing of breast tumors. Neoplasma. 1983;30(1):113–23. World Health Organization. Histological typing of breast tumors. Neoplasma. 1983;30(1):113–23.
4.
go back to reference Tse M, Koo JS, Thike AA. Phyllodes tumour. In: WHO Classification of Tumours Editorial Board. Breast tumours. Lyon (France): International Agency for Research on Cancer; 2019. pp. 172–6. (WHO classification of tumours series, 5th ed.; vol. 2). https://publications.iarc.fr/581. Tse M, Koo JS, Thike AA. Phyllodes tumour. In: WHO Classification of Tumours Editorial Board. Breast tumours. Lyon (France): International Agency for Research on Cancer; 2019. pp. 172–6. (WHO classification of tumours series, 5th ed.; vol. 2). https://​publications.​iarc.​fr/​581.
5.
go back to reference Belkacémi Y, Bousquet G, Marsiglia H, Ray-Coquard I, Magné N, Malard Y, et al. Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys. 2008;70(2):492–500.PubMedCrossRef Belkacémi Y, Bousquet G, Marsiglia H, Ray-Coquard I, Magné N, Malard Y, et al. Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys. 2008;70(2):492–500.PubMedCrossRef
6.
go back to reference Reinfuss M, Mituś J, Duda K, Stelmach A, Ryś J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer. 1996;77(5):910–6.PubMedCrossRef Reinfuss M, Mituś J, Duda K, Stelmach A, Ryś J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer. 1996;77(5):910–6.PubMedCrossRef
7.
go back to reference Kim S, Kim JY, Kim DH, Jung WH, Koo JS. Analysis of phyllodes tumor recurrence according to the histologic grade. Breast Cancer Res Treat. 2013;141(3):353–63.PubMedCrossRef Kim S, Kim JY, Kim DH, Jung WH, Koo JS. Analysis of phyllodes tumor recurrence according to the histologic grade. Breast Cancer Res Treat. 2013;141(3):353–63.PubMedCrossRef
8.
go back to reference Mituś JW, Blecharz P, Walasek T, Reinfuss M, Jakubowicz J, Kulpa J. Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast. World J Surg. 2016;40(2):323–8.PubMedCrossRef Mituś JW, Blecharz P, Walasek T, Reinfuss M, Jakubowicz J, Kulpa J. Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast. World J Surg. 2016;40(2):323–8.PubMedCrossRef
9.
go back to reference De Foucher T, Roussel H, Hivelin M, Rossi L, Cornou C, Bats AS, et al. Atypical distant metastasis of breast malignant phyllodes tumors: A case report and literature review. Case Rep Obstet Gynecol. 2017;2017:8963013.PubMedPubMedCentral De Foucher T, Roussel H, Hivelin M, Rossi L, Cornou C, Bats AS, et al. Atypical distant metastasis of breast malignant phyllodes tumors: A case report and literature review. Case Rep Obstet Gynecol. 2017;2017:8963013.PubMedPubMedCentral
10.
go back to reference Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer. 2006;107(9):2127–33.PubMedCrossRef Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer. 2006;107(9):2127–33.PubMedCrossRef
11.
go back to reference Aranda FI, Laforga JB, López JI. Phyllodes tumor of the breast. An immunohistochemical study of 28 cases with special attention to the role of myofibroblasts. Pathol Res Pract. 1994;190(5):474–81.PubMedCrossRef Aranda FI, Laforga JB, López JI. Phyllodes tumor of the breast. An immunohistochemical study of 28 cases with special attention to the role of myofibroblasts. Pathol Res Pract. 1994;190(5):474–81.PubMedCrossRef
12.
go back to reference Fernandez BB, Hernanzez FJ, Spindler W. Metastatic cystosarcoma phyllodes: a light and electron microscopic study. Cancer. 1976;37(4):1737–46.PubMedCrossRef Fernandez BB, Hernanzez FJ, Spindler W. Metastatic cystosarcoma phyllodes: a light and electron microscopic study. Cancer. 1976;37(4):1737–46.PubMedCrossRef
13.
go back to reference Vorherr H, Vorherr UF, Kutvirt DM, Key CR. Cystosarcoma phyllodes: epidemiology, pathohistology, pathobiology, diagnosis, therapy, and survival. Arch Gynecol. 1985;236(3):173–81.PubMedCrossRef Vorherr H, Vorherr UF, Kutvirt DM, Key CR. Cystosarcoma phyllodes: epidemiology, pathohistology, pathobiology, diagnosis, therapy, and survival. Arch Gynecol. 1985;236(3):173–81.PubMedCrossRef
14.
go back to reference Tan EY, Tan PH, Yong WS, Wong HB, Ho GJ, Yeo AW, et al. Recurrent phyllodes tumors of the breast: pathological features and clinical implications. ANZ J Surg. 2006;76:476–80.PubMedCrossRef Tan EY, Tan PH, Yong WS, Wong HB, Ho GJ, Yeo AW, et al. Recurrent phyllodes tumors of the breast: pathological features and clinical implications. ANZ J Surg. 2006;76:476–80.PubMedCrossRef
15.
go back to reference Strode M, Khoury T, Mangieri C, Takabe K. Update on the diagnosis and management of malignant phyllodes tumors of the breast. Breast. 2017;33:91–6.PubMedCrossRef Strode M, Khoury T, Mangieri C, Takabe K. Update on the diagnosis and management of malignant phyllodes tumors of the breast. Breast. 2017;33:91–6.PubMedCrossRef
18.
go back to reference Cohn-Cedermark G, Rutqvist LE, Rosendahl I, Silfverswärd C. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients. Cancer. 1991;68(9):2017–22.PubMedCrossRef Cohn-Cedermark G, Rutqvist LE, Rosendahl I, Silfverswärd C. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients. Cancer. 1991;68(9):2017–22.PubMedCrossRef
19.
go back to reference Cheng SP, Chang YC, Liu TP, Lee JJ, Tzen CY, Liu CL. Phyllodes tumor of the breast: the challenge persists. World J Surg. 2006;30(8):1414–21.PubMedCrossRef Cheng SP, Chang YC, Liu TP, Lee JJ, Tzen CY, Liu CL. Phyllodes tumor of the breast: the challenge persists. World J Surg. 2006;30(8):1414–21.PubMedCrossRef
20.
go back to reference Rajan PB, Cranor ML, Rosen PP. Cystosarcoma phyllodes in adolescent girls and young women: a study of 45 patients. Am J Surg Pathol. 1998;22(1):64–9.PubMedCrossRef Rajan PB, Cranor ML, Rosen PP. Cystosarcoma phyllodes in adolescent girls and young women: a study of 45 patients. Am J Surg Pathol. 1998;22(1):64–9.PubMedCrossRef
22.
go back to reference Röder K, Dittmer C, Thill M, Fischer D. Malignant pyhlloid tumor of the breast—a rarity. Senologie. 2009;6:A96. Röder K, Dittmer C, Thill M, Fischer D. Malignant pyhlloid tumor of the breast—a rarity. Senologie. 2009;6:A96.
23.
go back to reference Umpleby HC, Moore I, Royle GT, Guyer PB, Taylor I. An evaluation of the preoperative diagnosis and management of cystosarcoma phyllodes. Ann R Coll Surg Engl. 1989;71(5):285–8.PubMedPubMedCentral Umpleby HC, Moore I, Royle GT, Guyer PB, Taylor I. An evaluation of the preoperative diagnosis and management of cystosarcoma phyllodes. Ann R Coll Surg Engl. 1989;71(5):285–8.PubMedPubMedCentral
24.
go back to reference Rowell MD, Perry RR, Hsiu JG, Barranco SC. Phyllodes tumors. Am J Surg. 1993;165(3):376–9.PubMedCrossRef Rowell MD, Perry RR, Hsiu JG, Barranco SC. Phyllodes tumors. Am J Surg. 1993;165(3):376–9.PubMedCrossRef
25.
go back to reference Chua CL, Thomas A, Ng BK. Cystosarcoma phyllodes: a review of surgical options. Surgery. 1989;105(2 Pt 1):141–7.PubMed Chua CL, Thomas A, Ng BK. Cystosarcoma phyllodes: a review of surgical options. Surgery. 1989;105(2 Pt 1):141–7.PubMed
26.
go back to reference Pandey M, Mathew A, Kattoor J, Abraham EK, Mathew BS, Rajan B, et al. Malignant phyllodes tumor. Breast J. 2001;7(6):411–6.PubMedCrossRef Pandey M, Mathew A, Kattoor J, Abraham EK, Mathew BS, Rajan B, et al. Malignant phyllodes tumor. Breast J. 2001;7(6):411–6.PubMedCrossRef
27.
go back to reference Kapiris I, Nasiri N, A’Hern R, Healy V, Gui GP. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol. 2001;27(8):723–30.PubMedCrossRef Kapiris I, Nasiri N, A’Hern R, Healy V, Gui GP. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol. 2001;27(8):723–30.PubMedCrossRef
28.
go back to reference Grimes MM. Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations. Mod Pathol. 1992;5(3):232–9.PubMed Grimes MM. Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations. Mod Pathol. 1992;5(3):232–9.PubMed
29.
go back to reference Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases. Cancer. 1967;20(12):2090–9.PubMedCrossRef Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases. Cancer. 1967;20(12):2090–9.PubMedCrossRef
30.
go back to reference Agrawal PP, Mohanta PK, Sing K, Bahadur AK. Cystosarcoma pyhllodes with lymhn node metastasis. Commun Oncol. 2006;3:44–88.CrossRef Agrawal PP, Mohanta PK, Sing K, Bahadur AK. Cystosarcoma pyhllodes with lymhn node metastasis. Commun Oncol. 2006;3:44–88.CrossRef
31.
go back to reference Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, et al. Phyllodes tumours of the breast: a consensus review. Histopathology. 2016;68(1):5–21.PubMedPubMedCentralCrossRef Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, et al. Phyllodes tumours of the breast: a consensus review. Histopathology. 2016;68(1):5–21.PubMedPubMedCentralCrossRef
34.
go back to reference Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW, et al. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol. 2007;14(10):2961–70.PubMedCrossRef Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW, et al. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol. 2007;14(10):2961–70.PubMedCrossRef
35.
go back to reference Spanheimer PM, Murray MP, Zabor EC, Stempel M, Morrow M, Van Zee KJ, et al. Long-term outcomes after surgical treatment of malignant/borderline Phyllodes tumors of the breast. Ann Surg Oncol. 2019;26(7):2136–43.PubMedPubMedCentralCrossRef Spanheimer PM, Murray MP, Zabor EC, Stempel M, Morrow M, Van Zee KJ, et al. Long-term outcomes after surgical treatment of malignant/borderline Phyllodes tumors of the breast. Ann Surg Oncol. 2019;26(7):2136–43.PubMedPubMedCentralCrossRef
36.
go back to reference American Joint Committee On Cancer. AJCC cancer staging manual. Philadelphia: Lippincott Raven Publishers; 2002. American Joint Committee On Cancer. AJCC cancer staging manual. Philadelphia: Lippincott Raven Publishers; 2002.
37.
go back to reference Gnerlich JL, Williams RT, Yao K, Jaskowiak N, Kulkarni SA. Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998–2009. Ann Surg Oncol. 2014;21(4):1222–30.PubMedCrossRef Gnerlich JL, Williams RT, Yao K, Jaskowiak N, Kulkarni SA. Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998–2009. Ann Surg Oncol. 2014;21(4):1222–30.PubMedCrossRef
38.
go back to reference Kyriazoglou A, Zagouri F, Dimopoulos MA. Olaratumab administered in two cases of phyllodes tumour of the breast: end of the beginning? Esmo Open. 2019;4(3):e479.PubMedPubMedCentralCrossRef Kyriazoglou A, Zagouri F, Dimopoulos MA. Olaratumab administered in two cases of phyllodes tumour of the breast: end of the beginning? Esmo Open. 2019;4(3):e479.PubMedPubMedCentralCrossRef
Metadata
Title
Malignant phyllodes tumor of the breast with axillary lymph node metastasis: case report and review of the literature
Authors
Hubert Hauser
Robert Hammer
Helmut Schöllnast
Ursula Humer-Fuchs
Doris Kriegl
Michael Fuchsjäger
Ferdinand Schmidt
Marija Balic
Sigurd F. Lax
Publication date
27-04-2022
Publisher
Springer Vienna
Keyword
Metastasis
Published in
European Surgery / Issue 3/2022
Print ISSN: 1682-8631
Electronic ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-022-00760-0

Other articles of this Issue 3/2022

European Surgery 3/2022 Go to the issue